These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38172167)

  • 1. Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.
    Hamedifar H; Mirfattahi M; Khalili Ghomi M; Azizian H; Iraji A; Noori M; Moazzam A; Dastyafteh N; Nokhbehzaim A; Mehrpour K; Javanshir S; Mojtabavi S; Faramarzi MA; Larijani B; Hajimiri MH; Mahdavi M
    Sci Rep; 2024 Jan; 14(1):388. PubMed ID: 38172167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.
    Noori M; Rastak M; Halimi M; Ghomi MK; Mollazadeh M; Mohammadi-Khanaposhtani M; Sayahi MH; Rezaei Z; Mojtabavi S; Ali Faramarzi M; Larijani B; Biglar M; Amanlou M; Mahdavi M
    Bioorg Chem; 2022 Oct; 127():105996. PubMed ID: 35878449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
    Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors.
    Noori M; Davoodi A; Iraji A; Dastyafteh N; Khalili M; Asadi M; Mohammadi Khanaposhtani M; Mojtabavi S; Dianatpour M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2022 Aug; 12(1):14019. PubMed ID: 35982225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents.
    Shayegan N; Haghipour S; Tanideh N; Moazzam A; Mojtabavi S; Faramarzi MA; Irajie C; Parizad S; Ansari S; Larijani B; Hosseini S; Iraji A; Mahdavi M
    Sci Rep; 2023 Apr; 13(1):6304. PubMed ID: 37072431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
    Heydari Z; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Ranjbar PR; Larijani B
    Med Chem; 2019; 15(1):8-16. PubMed ID: 29807519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies.
    Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N
    Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties.
    Khalili Ghomi M; Noori M; Mirahmad M; Iraji A; Sadr AS; Dastyafteh N; Asili P; Gholami M; Javanshir S; Lotfi M; Mojtabavi S; Faramarzi MA; Asadi M; Nasli-Esfahani E; Palimi M; Larijani B; Meshkatalsadat MH; Mahdavi M
    Eur J Med Chem; 2024 Apr; 269():116332. PubMed ID: 38508120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based α-glucosidase inhibitors.
    Ghomi MK; Dastyafteh N; Montazer MN; Noori M; Mojtabavi S; Faramarzi MA; Hashemi SM; Mahdavi M
    Sci Rep; 2024 Jan; 14(1):501. PubMed ID: 38177164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid.
    Khan H; Jan F; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Ullah S; Al-Harrasi A; Khan M; Ali S
    Sci Rep; 2024 May; 14(1):11410. PubMed ID: 38762658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies.
    Imran S; Taha M; Ismail NH; Kashif SM; Rahim F; Jamil W; Hariono M; Yusuf M; Wahab H
    Eur J Med Chem; 2015 Nov; 105():156-70. PubMed ID: 26491979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.
    Taha M; Ismail NH; Javaid K; Imran S; Anouar el H; Wadood A; Atia-Tul-Wahab ; Ali M; Khan KM; Saad SM; Rahim F; Choudhary MI
    Bioorg Chem; 2015 Dec; 63():24-35. PubMed ID: 26398141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives.
    Asadi M; Ahangari MM; Iraji A; Azizian H; Nokhbehzaim A; Bahadorikhalili S; Mojtabavi S; Faramarzi MA; Nasli-Esfahani E; Larijani B; Mahdavi M; Amanlou M
    Sci Rep; 2024 Jul; 14(1):17338. PubMed ID: 39069559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
    Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
    Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches.
    Tasleem M; Ullah S; Halim SA; Urooj I; Ahmed N; Munir R; Khan A; El-Kott AF; Taslimi P; Negm S; Al-Harrasi A; Shafiq Z
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300544. PubMed ID: 38013251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
    Shah S; Arshia ; Javaid K; Zafar H; Mohammed Khan K; Khalil R; Ul-Haq Z; Perveen S; Iqbal Choudhary M
    Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.